Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Evaluation of a Health Behavior Intervention to Reduce Heart Disease Risk after Cancer Treatment in Patients with a History of Breast Cancer, HEART-ACT Trial

Trial Status: closed to accrual

This clinical trial evaluates an exercise and health behavior program (modeled after cardiac rehabilitation) in people with a history of breast cancer to find out whether it improves heart health after cancer treatment. Breast cancer survivors have 1.8 times the risk of cardiovascular mortality compared to women without breast cancer. This elevated risk is due to shared risk factors (e.g., obesity, tobacco use), side effects of some cancer treatments (e.g., cardiotoxic chemotherapy, hormone-related treatments, and radiation), and health behaviors (e.g., sedentary lifestyle, diet). This study may help researchers determine the impact of an exercise and health behavior program on heart disease risk in patients with breast cancer.